EP Patent

EP0914116A1 — Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere

Assigned to American Regent Inc · Expires 1999-05-12 · 27y expired

What this patent protects

This invention provides taxanes that are conjugates of cis-docosahexaenoic acid and taxotere. The conjugates are useful in treating cancer.

USPTO Abstract

This invention provides taxanes that are conjugates of cis-docosahexaenoic acid and taxotere. The conjugates are useful in treating cancer.

Drugs covered by this patent

Patent Metadata

Patent number: EP0914116A1
Jurisdiction: EP
Classification: —
Expires: 1999-05-12
Drug substance claim: No
Drug product claim: No
Assignee: American Regent Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.